According to Gate News bot, as reported by Wu, the Hong Kong listed company Pioneer Pharma (00399) has officially signed a memorandum of understanding to acquire all the shares of a company to obtain Conflux Blockchain related assets. The transaction price is planned to be paid in cash, shares, or convertible bonds, with the specific amount to be determined in the formal agreement.
According to the terms of the memorandum, the protocol is valid for 12 months, during which the seller shall not engage in relevant discussions with other parties. Navigating Pharmaceuticals is expanding its Blockchain business through this acquisition plan to achieve a diversified business layout.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Linhang Pharmaceuticals plans to acquire a company holding assets related to the Conflux Blockchain.
According to Gate News bot, as reported by Wu, the Hong Kong listed company Pioneer Pharma (00399) has officially signed a memorandum of understanding to acquire all the shares of a company to obtain Conflux Blockchain related assets. The transaction price is planned to be paid in cash, shares, or convertible bonds, with the specific amount to be determined in the formal agreement.
According to the terms of the memorandum, the protocol is valid for 12 months, during which the seller shall not engage in relevant discussions with other parties. Navigating Pharmaceuticals is expanding its Blockchain business through this acquisition plan to achieve a diversified business layout.